JOSEP M CRUZADO

Professor

University of Barcelona

Spain

Research Interests

Explore related searches

Professors in Spain

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Josep M Cruzado is a Professor at Universitat de Barcelona in Spain. His research focuses on renal transplantation, including pharmacokinetics, guidelines for sensitized patients, and kidney disease management. He has contributed to recent studies on the effects of calcineurin inhibitors, cancer risks in kidney transplant recipients, and the renal lifecycle trial assessing dapagliflozin. His work also addresses subclinical inflammation in renal allograft dysfunction and the recalibration of kidney failure risk equations.

Articles (10)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Collaborators (4)

Betlem Salvador-González

SPAIN

View details

Christoph Wanner

University of Oxford

UNITED KINGDOM

View details

Pere Fontova

Assistant Professor

University of Barcelona

SPAIN

View details

Josepa Ribes Puig

Catalan Institute of Oncology

SPAIN

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

JOSEP M CRUZADO

Research Interests

Explore related searches

Contact this professor

About

Articles (10)

Optimizing Dose Conversion from IR-Tac to LCP-Tac Formulations in Renal Transplant Recipients: A Population Pharmacokinetic Modeling Study

Spanish guidelines for kidney transplantation in highly sensitized patients with donor-specific anti-HLA antibodies

Delayed initiation or reduced initial dose of calcineurin-inhibitors for kidney transplant recipients at high risk of delayed graft function

Anti-slit Antibodies against Podocin and Kirrel1 in Pediatric and Adult Podocytopathies

Cancer risks in people on dialysis and kidney transplant recipients: a Catalan cohort study, 2003-2021

Rationale and design of the Renal Lifecycle Trial assessing the Effect of Dapagliflozin on Cardiorenal Outcomes in Severe Chronic Kidney Disease

Severe ischemia-reperfusion injury induces epigenetic inactivation of LHX1 in kidney progenitor cells after kidney transplantation

Subclinical inflammation and renal allograft dysfunction: myth or reality?

Management of Kidney Disease in Heart Transplant Patients: A National Delphi Survey-based Consensus Expert Paper

Recalibrating the kidney failure risk equation for a Mediterranean European population: reducing age and sex inequality

Collaborators (4)

Betlem Salvador-González

Christoph Wanner

Pere Fontova

Josepa Ribes Puig

Make your next move.